<DOC>
	<DOCNO>NCT00683657</DOCNO>
	<brief_summary>This protocol compare 24 hour glucose control subject take saxagliptin metformin extend release ( XR ) versus metformin XR alone</brief_summary>
	<brief_title>Safety Efficacy Study Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared Subjects Taking Metformin XR Alone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>≥18 ≤77yearsold Type 2 diabetes Taking metformin immediate release ( IR ) XR ≥1500 mg least 8 week monotherapy Glycosylated hemoglobin ( A1C ) ≥7 % ≤10 % Body mass index ( BMI ) ≤40 kg/m2 Women childbearing potential unable unwilling use acceptable birth control Women pregnant breastfeeding Significant cardiovascular history Active liver disease Renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>